{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:11:42Z","timestamp":1789783902731,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.ygyno.2012.12.007","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T04:46:15Z","timestamp":1355287575000},"page":"493-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes"],"prefix":"10.1016","volume":"128","author":[{"given":"Kathryn P.","family":"Pennington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneka","family":"Wickramanayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Norquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Pennil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rochelle L.","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy J.","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyasu","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piri","family":"Welcsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Swisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.12.007_bb0005","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0010","doi-asserted-by":"crossref","first-page":"8109","DOI":"10.1158\/0008-5472.CAN-06-0140","article-title":"Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition","volume":"66","author":"McCabe","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0015","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nm852","article-title":"Disruption of the Fanconi anemia-BRCA pathway in cisplatin-sensitive ovarian tumors","volume":"9","author":"Taniguchi","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.molcel.2011.03.019","article-title":"Regulation of DNA end joining, resection, and immunoglobulin class switch recombination by 53BP1","volume":"42","author":"Bothmer","year":"2011","journal-title":"Mol Cell"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0025","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.cell.2010.03.012","article-title":"53BP1 inhibits homologous recombination in Brca1-deficient cells by blocking resection of DNA breaks","volume":"141","author":"Bunting","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0030","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature07476","article-title":"53BP1 facilitates long-range DNA end-joining during V(D)J recombination","volume":"456","author":"Difilippantonio","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0035","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.200403021","article-title":"53BP1 is required for class switch recombination","volume":"165","author":"Ward","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0040","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.molcel.2007.12.005","article-title":"Distinct roles of chromatin-associated proteins MDC1 and 53BP1 in mammalian double-strand break repair","volume":"28","author":"Xie","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nsmb.1831","article-title":"53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers","volume":"17","author":"Bouwman","year":"2010","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.molcel.2012.02.015","article-title":"BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair","volume":"46","author":"Bunting","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0055","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2012.20","article-title":"Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer","volume":"307","author":"Bolton","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1200\/JCO.2007.11.6905","article-title":"Effect of BRCA1\/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer","volume":"26","author":"Chetrit","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0065","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1200\/JCO.2011.39.8545","article-title":"BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group","volume":"30","author":"Alsop","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0070","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1476-4598-8-48","article-title":"Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas","volume":"8","author":"Swisher","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0075","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/sj.onc.1202509","article-title":"Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics","volume":"18","author":"Catteau","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0080","first-page":"5329","article-title":"BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study","volume":"60","author":"Baldwin","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0085","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0002-9440(10)64059-X","article-title":"Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes","volume":"158","author":"Strathdee","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0090","doi-asserted-by":"crossref","first-page":"8961","DOI":"10.1158\/0008-5472.CAN-05-1187","article-title":"CpG island methylation of DNA damage response genes in advance ovarian cancer","volume":"65","author":"Teodoridis","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0095","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"The Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/ijgc-00009577-200602001-00026","article-title":"BRCA1 expression in a large series of sporadic ovarian carcinomas: a Gynecologic Oncology Group study","volume":"16","author":"Thrall","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0105","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0110","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1083\/jcb.151.7.1381","article-title":"p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks","volume":"151","author":"Schultz","year":"2000","journal-title":"J Cell Biol"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0115","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1038\/sj.onc.1210553","article-title":"DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumors","volume":"26","author":"Bartkova","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0120","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/6029","article-title":"Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas","volume":"21","author":"Wilson","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0125","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1200\/JCO.2010.34.2980","article-title":"Secondary somatic mutations restoring BRCA1\/2 predict chemotherapy resistance in hereditary ovarian carcinomas","volume":"29","author":"Norquist","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0130","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/jnci\/djs177","article-title":"A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy","volume":"104","author":"Kang","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ygyno.2012.12.007_bb0135","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1073\/pnas.1013715108","article-title":"Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells","volume":"108","author":"Patel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812009547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812009547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T03:37:24Z","timestamp":1758771444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812009547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0090825812009547"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.12.007","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"53BP1 expression in sporadic and inherited ovarian carcinoma: Relationship to genetic status and clinical outcomes","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}